411 related articles for article (PubMed ID: 27622244)
1. Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
Zhang Q; Feng Y; Kennedy D
Cell Mol Life Sci; 2017 Mar; 74(5):777-801. PubMed ID: 27622244
[TBL] [Abstract][Full Text] [Related]
2. IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model.
Gomez-Cabrero A; Wrasidlo W; Reisfeld RA
PLoS One; 2013; 8(8):e73607. PubMed ID: 24014113
[TBL] [Abstract][Full Text] [Related]
3. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
4. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer stem cells with natural products.
Burnett J; Newman B; Sun D
Curr Drug Targets; 2012 Jul; 13(8):1054-64. PubMed ID: 22594473
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
7. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Polypropylene Sulfide Magnetic Nanocarrier-Mediated Chemo-Hyperthermia Kills Breast Cancer Stem Cells by Long-Term Reversal of Multidrug Resistance and Chemotherapy Resensitization.
Basu SM; Chauhan M; Giri J
ACS Appl Mater Interfaces; 2023 Dec; 15(50):58151-58165. PubMed ID: 38063494
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: a potential target for cancer therapy.
Qiu H; Fang X; Luo Q; Ouyang G
Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
[TBL] [Abstract][Full Text] [Related]
10. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
Karthikeyan S; Hoti SL
Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
14. Natural Products That Target Cancer Stem Cells.
Moselhy J; Srinivasan S; Ankem MK; Damodaran C
Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
[TBL] [Abstract][Full Text] [Related]
15. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
16. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
Dinic J; Podolski-Renic A; Stankovic T; Bankovic J; Pesic M
Curr Pharm Des; 2015; 21(38):5589-604. PubMed ID: 26429711
[TBL] [Abstract][Full Text] [Related]
17. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.
Mishra A; Pathak Y; Mishra SK; Prakash H; Tripathi V
Eur J Pharmacol; 2023 Jan; 938():175412. PubMed ID: 36427534
[TBL] [Abstract][Full Text] [Related]
18. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
19. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
